James Stuttle

Head Pharma IP Operations at Novartis - Basel, Basel-City, CH

James Stuttle's Colleagues at Novartis
Nigel Cooke

Due Diligence Head, Oncology

Contact Nigel Cooke

Adrian Waldner

Global Head Pharmacovigilance

Contact Adrian Waldner

Bernhard Gobeli

Head of Sales Switzerland

Contact Bernhard Gobeli

Joost Louwagie

Due Diligence Head, Global Drug Development BD&L + M&A

Contact Joost Louwagie

Gwennaelle Monnot

Principal Scientist (Lab head)

Contact Gwennaelle Monnot

Peter Koerfgen

Region Head Corporate Country Communications

Contact Peter Koerfgen

View All James Stuttle's Colleagues
James Stuttle's Contact Details
HQ
+41 61 324 11 11
Location
Basel,Basel-Stadt,Switzerland
Company
Novartis
James Stuttle's Company Details
Novartis logo, Novartis contact details

Novartis

Basel, Basel-City, CH • 79173 Employees
Major Drugs

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Pharmaceutical Drugs Innovative Medicine Healthcare Solution Biotechnology Medical Research Clinical Trials Pharmaceutical Manufacturing Drug Development And Manufacturing Health Technology
Details about Novartis
Frequently Asked Questions about James Stuttle
James Stuttle currently works for Novartis.
James Stuttle's role at Novartis is Head Pharma IP Operations.
James Stuttle's email address is ***@novartis.com. To view James Stuttle's full email address, please signup to ConnectPlex.
James Stuttle works in the Major Drugs industry.
James Stuttle's colleagues at Novartis are Nigel Cooke, Adrian Waldner, Bernhard Gobeli, Joost Louwagie, Gwennaelle Monnot, Peter Koerfgen, Elisa Garcia and others.
James Stuttle's phone number is +41 61 324 11 11
See more information about James Stuttle